查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1971525

外科/銳器清創市場 - 全球產業規模、佔有率、趨勢、機會、預測、區域及競爭格局（2021-2031）

Surgical/Sharp Debridement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球外科/銳器清創市場預計將從 2025 年的 2.3444 億美元成長到 2031 年的 3.1941 億美元，複合年成長率為 5.29%。

此手術包括使用無菌器械（例如剪刀和手術刀）切除壞死和感染組織，從而促進健康組織的再生。推動此成長要素包括慢性疾病（尤其是糖尿病足潰瘍）發生率的上升，以及全球人口老化導致複雜傷口增加。根據國際糖尿病聯盟2024年的數據，全球約有5.89億成年人患有糖尿病，這一數字凸顯了有效潰瘍管理的日益成長的需求。此外，術後環境中嚴格的感染控制也是此手術持續發展的重要原因。

市場概覽
預測期 2027-2031
市場規模：2025年 2.3444億美元
市場規模：2031年 3.1941億美元
複合年成長率：2026-2031年 5.29%
成長最快的細分市場
最大的市場 北美洲

另一方面，阻礙市場發展的主要障礙是全球範圍內掌握這項侵入性技術的醫療專業人員短缺。銳器清創術需要極高的精準度以避免損傷健康組織，而合格專業人員的匱乏限制了患者獲得這些必要治療的機會。這種臨床專業知識的缺乏常常迫使醫療機構採用速度較慢、效率較低的保守治療策略，限制了市場滲透率的提升。

市場促進因素

全球肥胖及其相關代謝疾病的日益流行，是外科清創領域發展的重要驅動力。高體重指數（BMI）族群常伴隨靜脈功能不全和循環障礙，導致複雜的潰瘍，需要精準切除壞死組織以促進癒合。世界衛生組織（WHO）在2024年3月「世界肥胖日」發布的新聞稿中指出，全球超過10億人患有肥胖症，這群人極易發生與皮膚健康相關的併發症。如此龐大的患者群體需要定期進行徹底清創，以控制微生物附著量（微生物負荷）並預防全身性行為感染，從而確保了對熟練的清創醫師和無菌清創器械的穩定臨床需求。

同時，對先進創傷護理管理的需求日益成長，使得清創術的使用顯著增加，並成為後續治療的先決條件。細胞療法和負壓傷口治療等先進療法依賴於清除壞死組織的清潔傷口床，而清創術正是實現這一通訊協定的有效途徑。例如，史密斯醫療（Smith & Nephew）在其2024年2月發布的2023會計年度年度報告中指出，其先進傷口管理部門創造了16億美元的收入，這充分說明了這些綜合護理方案的規模。此外，根據Healogics公司2024年的數據，美國約有670萬人患有難以癒合的慢性傷口，凸顯了需要積極進行維護性清創以降低發病率的病例的緊迫性。

市場挑戰

熟練醫護人員的短缺是外科/銳器清創領域發展的主要障礙。與自動化治療方案不同，銳器清創術是一項勞動密集且侵入性強的手術，需要精湛的技巧和良好的臨床判斷才能安全地清除壞死組織。此手術的成功完全取決於能否獲得專業的創傷護理護理師和認證外科醫生。因此，這些合格專業人員的短缺造成了診所和醫院的營運瓶頸，從物理上限制了可進行的手術數量，並直接阻礙了潛在的產生收入。

近期統計數據顯示，專科醫師的供應缺口日益擴大，進一步印證了這個短缺問題。美國醫學院協會（AAMC）預測，到2036年，醫療產業將面臨1萬至1.99萬名外科醫師的缺口。專科醫師的短缺迫使醫療機構以自體溶解和酵素療法等保守療法取代銳性清創術。雖然這些療法減輕了醫護人員的負擔，但也導致手術頻率和患者周轉率下降，最終阻礙了市場的整體經濟成長。

市場趨勢

人工智慧驅動的傷口評估和記錄系統的引入正在改變市場格局，它能夠自動測量壞死組織，並規範銳性清創術的臨床證據。人工智慧演算法使臨床醫生只需拍攝傷口影像即可自動計算組織成分和表面積，從而實現精確的時間序列監測，同時最大限度地減少手動測量的主觀性。這種數位化檢驗在基於價值的醫療體系下對於報銷至關重要，它為侵入性清除壞死組織的必要性提供了無可辯駁的證據。 Swift Medical 於 2024 年 1 月發布的新聞稿證實了這一趨勢，該新聞稿宣布了新一輪資金籌措，並指出其人工智慧增強平台已被北美 4000 多家醫療機構使用，這表明數位化工具正在迅速滲透到臨床工作流程中。

此外，即時生物膜引導螢光成像技術的引入，標誌著清創過程中從依賴臨床症狀轉向客觀細菌可視化的重大轉變。此技術能夠即時顯示生物膜細菌，引導臨床醫師操作器械，確保徹底清除肉眼難以察覺的定植組織。這種精準性顯著提高了傷口床準備的有效性，並比經常漏診皮下感染的標準護理方法更有效地降低微生物附著量。在2024年10月發布的新聞稿《MolecuLight螢光成像：床邊生物膜檢測的變革者》中，對比研究表明，螢光成像在生物膜檢測方面具有高達84%的靈敏度，顯著優於傳統的視覺評估方法。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球外科/銳器清創市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美外科/銳器清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲外科/銳器清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區外科/銳器清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲外科/銳器清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲外科/銳器清創市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球外科/銳器清創市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Smith & Nephew plc
  • Medtronic plc
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Integra LifeSciences Corporation
  • CONMED Corporation
  • Coloplast A/S
  • Johnson & Johnson
  • 3M Company
  • DeRoyal Industries, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27192

The Global Surgical or Sharp Debridement Market is projected to expand from USD 234.44 Million in 2025 to USD 319.41 Million by 2031, reflecting a compound annual growth rate (CAGR) of 5.29%. This procedure entails the use of sterile instruments, such as scissors or scalpels, to excise necrotic or infected tissue and stimulate the regeneration of healthy tissue. A primary growth driver is the rising incidence of chronic ailments, specifically diabetic foot ulcers, alongside an aging global demographic prone to complex wounds. Data from the International Diabetes Federation in 2024 indicates that roughly 589 million adults globally were living with diabetes, a statistic that underscores the escalating need for effective ulcer management. Furthermore, the essential need for rigorous infection control in post-surgical settings provides foundational support for the continued demand for these interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 234.44 Million
Market Size 2031USD 319.41 Million
CAGR 2026-20315.29%
Fastest Growing Segment
Largest MarketNorth America

Conversely, a major obstacle hindering market progression is the worldwide scarcity of healthcare professionals proficient in this invasive technique. Sharp debridement demands distinct precision to prevent harm to viable tissue, and the lack of certified specialists restricts patient access to these necessary treatments. This deficiency in clinical expertise frequently compels healthcare providers to utilize slower, less efficient conservative management tactics, which ultimately limits broader market penetration.

Market Driver

The escalating global prevalence of obesity and associated metabolic disorders acts as a significant propellant for the surgical debridement sector. Individuals with high body mass indices frequently experience venous insufficiency and compromised circulation, resulting in complex ulcers that demand the precise excision of devitalized tissue to trigger healing processes. As per the 'World Obesity Day 2024' news release by the World Health Organization in March 2024, over 1 billion individuals globally were living with obesity, creating a demographic highly susceptible to skin integrity complications. This substantial patient population requires regular sharp debridement to control bioburden and avert systemic infections, thereby ensuring a steady clinical demand for skilled practitioners and sterile debridement tools.

Concurrently, the rising request for advanced wound care management significantly boosts the utilization of sharp debridement as an essential prerequisite for follow-up therapies. Advanced treatments, such as cellular-based products or negative pressure wound therapy, depend on a clean wound bed devoid of necrosis, a condition effectively achieved through sharp debridement. Highlighting the scale of these integrated care protocols, Smith+Nephew reported in February 2024 within their 'Annual Report 2023' that their Advanced Wound Management division secured $1.6 billion in revenue. Moreover, data from Healogics in 2024 indicated that approximately 6.7 million individuals in the United States were affected by non-healing chronic wounds, emphasizing the urgent volume of cases necessitating aggressive maintenance debridement to lower morbidity rates.

Market Challenge

The lack of proficient healthcare professionals poses a formidable hurdle to the growth of the surgical or sharp debridement sector. Unlike automated therapeutic options, sharp debridement is a labor-intensive, invasive process requiring exceptional manual dexterity and sound clinical judgment to safely remove necrotic tissue. The success of the procedure relies entirely on the accessibility of specialized wound care nurses and board-certified surgeons. As a result, the shortage of these qualified experts generates operational bottlenecks within clinics and hospitals, physically restricting the volume of performable procedures and directly limiting potential revenue generation.

Recent statistics regarding the widening gap in specialist availability further corroborate this workforce limitation. According to the Association of American Medical Colleges in 2024, the healthcare industry is expected to encounter a surgeon shortfall ranging from 10,000 to 19,900 by 2036. This scarcity of available specialists obliges healthcare providers to replace sharp debridement with conservative alternatives, such as autolytic or enzymatic methods. Although these substitutes place fewer demands on staff, they lead to reduced procedure frequency and slower patient turnover, thereby impeding the overall financial expansion of the market.

Market Trends

The adoption of AI-Driven Wound Assessment and Documentation is transforming the market by automating the measurement of necrotic tissue, thereby standardizing the clinical rationale for sharp debridement. Artificial intelligence algorithms now enable clinicians to capture wound imagery that automatically computes tissue composition and surface area, minimizing the subjectivity inherent in manual measurements while ensuring precise longitudinal monitoring. This digital verification is becoming essential for reimbursement within value-based care frameworks, offering irrefutable proof of the need for the invasive removal of devitalized tissue. As evidence of this trend, Swift Medical's 'Swift Medical Announces New Financing Round' press release in January 2024 noted that their AI-enhanced platform is now utilized by over 4,000 healthcare facilities in North America, signaling the rapid assimilation of digital tools into clinical workflows.

Additionally, the incorporation of Fluorescence Imaging for Real-Time Biofilm Guidance marks a pivotal transition from reliance on clinical symptoms to the use of objective bacterial visualization during debridement. This technology highlights biofilm bacteria in real-time, directing the clinician's instruments to guarantee the thorough removal of colonized tissue that might otherwise escape detection by the naked eye. Such precision vastly enhances the effectiveness of wound bed preparation, reducing bioburden more proficiently than standard care methods which frequently fail to identify sub-surface infections. In an October 2024 news release titled 'MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection,' a comparative study demonstrated that fluorescence imaging provided a superior sensitivity rate of 84% for biofilm detection, substantially exceeding the limits of traditional visual assessment.

Key Market Players

  • Smith & Nephew plc
  • Medtronic plc
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Integra LifeSciences Corporation
  • CONMED Corporation
  • Coloplast A/S
  • Johnson & Johnson
  • 3M Company
  • DeRoyal Industries, Inc.

Report Scope

In this report, the Global Surgical or Sharp Debridement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Surgical or Sharp Debridement Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Surgical or Sharp Debridement Market.

Available Customizations:

Global Surgical or Sharp Debridement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Surgical or Sharp Debridement Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Region
    • 5.2.2. By Company (2025)
  • 5.3. Market Map

6. North America Surgical or Sharp Debridement Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Surgical or Sharp Debridement Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
    • 6.3.2. Canada Surgical or Sharp Debridement Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
    • 6.3.3. Mexico Surgical or Sharp Debridement Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast

7. Europe Surgical or Sharp Debridement Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Surgical or Sharp Debridement Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
    • 7.3.2. France Surgical or Sharp Debridement Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
    • 7.3.3. United Kingdom Surgical or Sharp Debridement Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
    • 7.3.4. Italy Surgical or Sharp Debridement Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
    • 7.3.5. Spain Surgical or Sharp Debridement Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast

8. Asia Pacific Surgical or Sharp Debridement Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Surgical or Sharp Debridement Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
    • 8.3.2. India Surgical or Sharp Debridement Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
    • 8.3.3. Japan Surgical or Sharp Debridement Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
    • 8.3.4. South Korea Surgical or Sharp Debridement Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
    • 8.3.5. Australia Surgical or Sharp Debridement Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast

9. Middle East & Africa Surgical or Sharp Debridement Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Surgical or Sharp Debridement Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
    • 9.3.2. UAE Surgical or Sharp Debridement Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
    • 9.3.3. South Africa Surgical or Sharp Debridement Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast

10. South America Surgical or Sharp Debridement Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Surgical or Sharp Debridement Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
    • 10.3.2. Colombia Surgical or Sharp Debridement Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
    • 10.3.3. Argentina Surgical or Sharp Debridement Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Surgical or Sharp Debridement Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Smith & Nephew plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic plc
  • 15.3. B. Braun Melsungen AG
  • 15.4. Stryker Corporation
  • 15.5. Integra LifeSciences Corporation
  • 15.6. CONMED Corporation
  • 15.7. Coloplast A/S
  • 15.8. Johnson & Johnson
  • 15.9. 3M Company
  • 15.10. DeRoyal Industries, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer